Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy
- PMID: 19377068
- DOI: 10.1093/cvr/cvp119
Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy
Abstract
Aims: Z-band alternatively spliced PDZ-motif protein (ZASP)/Cypher is a Z-disc component of which several dilated cardiomyopathy (DCM)-associated mutations have been reported. Most of the mutations were found in exons 4 and 10 of ZASP/Cypher gene LDB3 and both exons were expressed preferentially in the heart. The aim of this study was to investigate the functional alteration of ZASP/Cypher caused by the DCM-associated mutations.
Methods and results: The yeast-two-hybrid method was used to identify the protein bound to a domain encoded by exon 4 of LDB3. Interaction of ZASP/Cypher with the binding protein was investigated in relation to the functional alterations caused by LDB3 mutations. Localization of the ZASP/Cypher-binding protein was examined at the cellular level in rat cardiomyocytes. Phosphoglucomutase 1 (PGM1), a metabolic enzyme involved in glycolysis and gluconeogenesis, was identified as a protein interacting with ZASP/Cypher. PGM1 bound to ZASP/Cypher at the domains encoded by exons 4 and 10. Two LDB3 mutations in exon 4 (Ser189Leu and Thr206Ile) and another mutation in exon 10 (Ile345Met) reduced the binding to PGM1. PGM1 showed diffuse localization in the cytoplasm of rat cardiomyocytes under standard culture conditions, and distribution at the Z-discs was observed under stressed culture conditions. Binding of endogenous PGM1 and ZASP/Cypher was found to be enhanced by stress in rat cardiomyocytes.
Conclusion: ZASP/Cypher anchors PGM1 to Z-disc under conditions of stress. The impaired binding of PGM1 to ZASP/Cypher might be involved in the pathogenesis of DCM.
Similar articles
-
Zasp/Cypher internal ZM-motif containing fragments are sufficient to co-localize with alpha-actinin--analysis of patient mutations.Exp Cell Res. 2006 May 1;312(8):1299-311. doi: 10.1016/j.yexcr.2005.12.036. Epub 2006 Feb 14. Exp Cell Res. 2006. PMID: 16476425
-
Cypher/ZASP drives cardiomyocyte maturation via actin-mediated MRTFA-SRF signalling.Theranostics. 2024 Jul 22;14(11):4462-4480. doi: 10.7150/thno.98734. eCollection 2024. Theranostics. 2024. PMID: 39113806 Free PMC article.
-
A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C.J Biol Chem. 2004 Feb 20;279(8):6746-52. doi: 10.1074/jbc.M311849200. Epub 2003 Dec 3. J Biol Chem. 2004. PMID: 14660611
-
"Z"eroing in on the role of Cypher in striated muscle function, signaling, and human disease.Trends Cardiovasc Med. 2007 Nov;17(8):258-62. doi: 10.1016/j.tcm.2007.09.002. Trends Cardiovasc Med. 2007. PMID: 18021935 Free PMC article. Review.
-
Advances in the role and mechanism of BAG3 in dilated cardiomyopathy.Heart Fail Rev. 2021 Jan;26(1):183-194. doi: 10.1007/s10741-019-09899-7. Heart Fail Rev. 2021. PMID: 31808029 Review.
Cited by
-
Z-disc-associated, alternatively spliced, PDZ motif-containing protein (ZASP) mutations in the actin-binding domain cause disruption of skeletal muscle actin filaments in myofibrillar myopathy.J Biol Chem. 2014 May 9;289(19):13615-26. doi: 10.1074/jbc.M114.550418. Epub 2014 Mar 25. J Biol Chem. 2014. PMID: 24668811 Free PMC article.
-
Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.Mol Genet Metab. 2024 Aug;142(4):108513. doi: 10.1016/j.ymgme.2024.108513. Epub 2024 Jun 13. Mol Genet Metab. 2024. PMID: 38917675 Free PMC article.
-
CDG Therapies: From Bench to Bedside.Int J Mol Sci. 2018 Apr 27;19(5):1304. doi: 10.3390/ijms19051304. Int J Mol Sci. 2018. PMID: 29702557 Free PMC article. Review.
-
Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function.J Inherit Metab Dis. 2015 Mar;38(2):243-56. doi: 10.1007/s10545-014-9757-9. Epub 2014 Aug 29. J Inherit Metab Dis. 2015. PMID: 25168163 Review.
-
Limitations of galactose therapy in phosphoglucomutase 1 deficiency.Mol Genet Metab Rep. 2017 Jul 31;13:33-40. doi: 10.1016/j.ymgmr.2017.07.010. eCollection 2017 Dec. Mol Genet Metab Rep. 2017. PMID: 28794993 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous